The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.
After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.
Multidisciplinary diagnostic stewardship programs safely decreased blood culture collection and antibiotics for pediatric intensive care patients, according to findings published in JAMA Pediatrics.
Investigators have discovered striking genetic differences in subsets of fetal immune cells, providing insight into morbidity related to premature birth.
Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.
A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.
Living in U.S. counties with higher concentrations of poverty was associated with increased risk of firearm-related deaths among children and young adults, according to a recent study.